<code id='212196CE19'></code><style id='212196CE19'></style>
    • <acronym id='212196CE19'></acronym>
      <center id='212196CE19'><center id='212196CE19'><tfoot id='212196CE19'></tfoot></center><abbr id='212196CE19'><dir id='212196CE19'><tfoot id='212196CE19'></tfoot><noframes id='212196CE19'>

    • <optgroup id='212196CE19'><strike id='212196CE19'><sup id='212196CE19'></sup></strike><code id='212196CE19'></code></optgroup>
        1. <b id='212196CE19'><label id='212196CE19'><select id='212196CE19'><dt id='212196CE19'><span id='212196CE19'></span></dt></select></label></b><u id='212196CE19'></u>
          <i id='212196CE19'><strike id='212196CE19'><tt id='212196CE19'><pre id='212196CE19'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:573
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          Ionis has late
          Ionis has late

          AdobeIonisPharmaceuticals,aCaliforniabiotechthathasspearheadedthedevelopmentofRNA-targetingmedicines

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Argenx drug significantly slows progression of nerve disorder

          AdobeBelgiandrugmakerArgenxsaidMondaythatitsantibodytreatmentcalledVyvgartsignificantlydelayedthepro